Showing results (301-310 of 424) with videos related to

Sort By:
Pageof 43
Journal of Hepatology|July 20, 2014
Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis CJean-Pierre Bronowicki, Vlad Ratziu, Adrian Gadano, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirinJohn G McHutchison, Thierry Poynard, Rafael Esteban-Mur, et al.
Gastroenterology|March 15, 2017
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia VasculitisDavid Saadoun, Stanislas Pol, Yasmina Ferfar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitisVlad Ratziu, Pierre Bedossa, Sven M Francque, et al.
Gastroenterology|October 31, 2002
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infectionLaurent Alric, Vincent Di-Martino, Janik Selves, et al.
Communications Medicine|July 16, 2024
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitisElena Sena, Frank Tacke, Quentin M Anstee, et al.
Gut|December 31, 2025
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunitiesXiao-Dong Zhou, Qiong-Yue Fan, Christopher D Byrne, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Comparative Hepatology|January 23, 2003
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver diseasePhilippe Halfon, Françoise Imbert-Bismut, Djamila Messous, et al.
Scientific Reports|March 4, 2020
Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosisCéline Hoffmann, Nour El Houda Djerir, Anne Danckaert, et al.
Pageof 43